CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 151,308	$ (41,704)	$ (122,404)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
(Gain) loss on impairments and disposal of assets	(71)	2,584	5,437
Amortization of intangibles	5,190	5,889	7,694
Depreciation	16,459	18,300	19,070
Non-cash compensation expense	29,457	28,579	39,682
Deferred income taxes	(129,751)	2,793	(4,692)
Bad debt expense	264	171	1,752
Amortization of debt issuance costs	1,609	2,168	3,137
Amortization of debt discount	498	331	0
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities	(1,926)	(2,839)	(4,404)
Gain on settlement of convertible debt	(266)	(9,035)	(48,562)
Impairment of long-lived assets	0	0	38,600
Changes in assets and liabilities:
Accounts receivable	(13,056)	(43,007)	27,706
Prepaid and other assets	(13,586)	(4,747)	(2,977)
Accounts payable, accrued expenses and other current liabilities	19,990	44,581	(5,541)
Income taxes receivable	(2,166)	96	(140)
Other, net	64	(278)	(1,291)
Net cash provided by operating activities	73,103	62,258	67,571
Cash flows from investing activities
Capital expenditures	(12,423)	(11,220)	(12,528)
Proceeds from the sale of fixed assets	2,497	0	0
Other investing activities	0	2	50
Net cash used in investing activities	(9,926)	(11,218)	(12,478)
Cash flows from financing activities
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options	(2,789)	(2,186)	(1,088)
Proceeds from term loan	450,000	125,000	0
Repayment of term loan	(410,375)	(12,500)	(1,875)
Payment of debt issuance costs	(5,095)	(4,300)	(1,580)
Payment of original issue discount on term loan	(4,000)	(3,125)	0
Other financing activities	0	(552)	1
Net cash used in financing activities	(88,698)	(56,502)	(242,006)
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents	(25,521)	(5,462)	(186,913)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period	106,594	112,056	298,969
Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period	81,073	106,594	112,056
Non-cash investing activities:
Increase (decrease) in capital expenditures included in accounts payable and accrued expenses	(170)	128	(377)
Supplemental cash flow information:
Interest paid	37,203	38,203	23,685
Income tax payments	1,772	1,676	1,283
Income tax refunds	238	220	100
Convertible Debt
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Loss on impairment of equity investments	1,225	58,376	114,504
Secured Debt
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Loss on impairment of equity investments	7,861	0	0
2025 Convertible Notes
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Amortization of debt issuance costs	300	1,000	2,200
Gain on settlement of convertible debt		(10,100)	(53,300)
Cash flows from financing activities
Repayment and repurchase of 0.50% Convertible Senior Notes	(115,007)	(158,839)	(237,464)
Payment of revolver issuance costs	$ (1,432)	$ 0	$ 0